Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03497377Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Comparison of DCFPyL- PET/CT to NaF-PET/CT at 4 years. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03497377.